This Experimental Drug Could Be a Game Changer for Pancreatic Cancer

by
Ed Cara
from Gizmodo on (#74YAZ)
Story ImageIn a Phase III trial, Revolution Medicines' daraxonrasib almost doubled the survival length of people with advanced pancreatic cancer.
External Content
Source RSS or Atom Feed
Feed Location http://gizmodo.com/rss
Feed Title Gizmodo
Feed Link https://gizmodo.com/
Reply 0 comments